Skip to content

Clinical trials

Observational Carotid Artery Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carotid Artery Diseases Phase: Observational Clear all

129 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20036
20052
20067
20071
20081
20093
20103
20113
201210
20131
20146
20154
20163
20175
20186
20197
20207
20219
20229
20234
20245
20254
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Unknown status39
Recruiting18
Withdrawn8
Terminated5
Enrolling by invitation3
Not yet recruiting2
Suspended1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)9
Silk Road Medical5
Columbia University4
Fondazione Policlinico Universitario Agostino Gemelli IRCCS4
Abbott Medical Devices2
Elucid Bioimaging Inc.2
First Affiliated Hospital Xi'an Jiaotong University2
John Paul II Hospital, Krakow2
Neuromed IRCCS2
Rush University Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carotid Artery Diseases129
Atherosclerosis36
Cardiovascular Diseases25
Carotid Stenosis25
Stroke24
Heart Diseases20
Coronary Artery Disease10
Coronary Disease8
Plaque, Atherosclerotic8
Ischemic Attack, Transient7

Trials

Showing 26 to 50 of 129. Each trial links to its page on Pharma Observatory.

29 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.